This report aims to provide a comprehensive presentation of the global market for Fibrate Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fibrate Drugs. This report contains market size and forecasts of Fibrate Drugs in global, including the following market information:
Global Fibrate Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Fibrate Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Lofibrate Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Fibrate Drugs include Teva Pharmaceutical Industries, Pfizer, Inc., Mylan N.V., Sanofi SA, Novartis AG, GlaxoSmithKline plc, Sun Pharmaceutical Industries, Inc., Macleods Pharmaceuticals Limited and Aurobindo Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Fibrate Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fibrate Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Fibrate Drugs Market Segment Percentages, by Type, 2022 (%)
- Lofibrate
- Fenofibrates
- Fenofibric Acids
- Gemfibrozil
Global Fibrate Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Fibrate Drugs Market Segment Percentages, by Application, 2022 (%)
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Fibrate Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Fibrate Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Fibrate Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Fibrate Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Teva Pharmaceutical Industries
- Pfizer, Inc.
- Mylan N.V.
- Sanofi SA
- Novartis AG
- GlaxoSmithKline plc
- Sun Pharmaceutical Industries, Inc.
- Macleods Pharmaceuticals Limited
- Aurobindo Pharma
- Abbott
Outline of Major Chapters:
Chapter 1: Introduces the definition of Fibrate Drugs, market overview.
Chapter 2: Global Fibrate Drugs market size in revenue.
Chapter 3: Detailed analysis of Fibrate Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments
by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments
by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Fibrate Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Fibrate Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Fibrate Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Fibrate Drugs Overall Market Size
2.1 Global Fibrate Drugs Market Size: 2022 VS 2029
2.2 Global Fibrate Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Fibrate Drugs Players in Global Market
3.2 Top Global Fibrate Drugs Companies Ranked by Revenue
3.3 Global Fibrate Drugs Revenue by Companies
3.4 Top 3 and Top 5 Fibrate Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Fibrate Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Fibrate Drugs Players in Global Market
3.6.1 List of Global Tier 1 Fibrate Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Fibrate Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Fibrate Drugs Market Size Markets, 2022 & 2029
4.1.2 Lofibrate
4.1.3 Fenofibrates
4.1.4 Fenofibric Acids
4.1.5 Gemfibrozil
4.2 By Type - Global Fibrate Drugs Revenue & Forecasts
4.2.1 By Type - Global Fibrate Drugs Revenue, 2018-2023
4.2.2 By Type - Global Fibrate Drugs Revenue, 2024-2029
4.2.3 By Type - Global Fibrate Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Fibrate Drugs Market Size, 2022 & 2029
5.1.2 Hospitals Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Fibrate Drugs Revenue & Forecasts
5.2.1 By Application - Global Fibrate Drugs Revenue, 2018-2023
5.2.2 By Application - Global Fibrate Drugs Revenue, 2024-2029
5.2.3 By Application - Global Fibrate Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Fibrate Drugs Market Size, 2022 & 2029
6.2 By Region - Global Fibrate Drugs Revenue & Forecasts
6.2.1 By Region - Global Fibrate Drugs Revenue, 2018-2023
6.2.2 By Region - Global Fibrate Drugs Revenue, 2024-2029
6.2.3 By Region - Global Fibrate Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Fibrate Drugs Revenue, 2018-2029
6.3.2 US Fibrate Drugs Market Size, 2018-2029
6.3.3 Canada Fibrate Drugs Market Size, 2018-2029
6.3.4 Mexico Fibrate Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Fibrate Drugs Revenue, 2018-2029
6.4.2 Germany Fibrate Drugs Market Size, 2018-2029
6.4.3 France Fibrate Drugs Market Size, 2018-2029
6.4.4 U.K. Fibrate Drugs Market Size, 2018-2029
6.4.5 Italy Fibrate Drugs Market Size, 2018-2029
6.4.6 Russia Fibrate Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Fibrate Drugs Market Size, 2018-2029
6.4.8 Benelux Fibrate Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Fibrate Drugs Revenue, 2018-2029
6.5.2 China Fibrate Drugs Market Size, 2018-2029
6.5.3 Japan Fibrate Drugs Market Size, 2018-2029
6.5.4 South Korea Fibrate Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Fibrate Drugs Market Size, 2018-2029
6.5.6 India Fibrate Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Fibrate Drugs Revenue, 2018-2029
6.6.2 Brazil Fibrate Drugs Market Size, 2018-2029
6.6.3 Argentina Fibrate Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Fibrate Drugs Revenue, 2018-2029
6.7.2 Turkey Fibrate Drugs Market Size, 2018-2029
6.7.3 Israel Fibrate Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Fibrate Drugs Market Size, 2018-2029
6.7.5 UAE Fibrate Drugs Market Size, 2018-2029
7 Fibrate Drugs Companies Profiles
7.1 Teva Pharmaceutical Industries
7.1.1 Teva Pharmaceutical Industries Company Summary
7.1.2 Teva Pharmaceutical Industries Business Overview
7.1.3 Teva Pharmaceutical Industries Fibrate Drugs Major Product Offerings
7.1.4 Teva Pharmaceutical Industries Fibrate Drugs Revenue in Global Market (2018-2023)
7.1.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.2 Pfizer, Inc.
7.2.1 Pfizer, Inc. Company Summary
7.2.2 Pfizer, Inc. Business Overview
7.2.3 Pfizer, Inc. Fibrate Drugs Major Product Offerings
7.2.4 Pfizer, Inc. Fibrate Drugs Revenue in Global Market (2018-2023)
7.2.5 Pfizer, Inc. Key News & Latest Developments
7.3 Mylan N.V.
7.3.1 Mylan N.V. Company Summary
7.3.2 Mylan N.V. Business Overview
7.3.3 Mylan N.V. Fibrate Drugs Major Product Offerings
7.3.4 Mylan N.V. Fibrate Drugs Revenue in Global Market (2018-2023)
7.3.5 Mylan N.V. Key News & Latest Developments
7.4 Sanofi SA
7.4.1 Sanofi SA Company Summary
7.4.2 Sanofi SA Business Overview
7.4.3 Sanofi SA Fibrate Drugs Major Product Offerings
7.4.4 Sanofi SA Fibrate Drugs Revenue in Global Market (2018-2023)
7.4.5 Sanofi SA Key News & Latest Developments
7.5 Novartis AG
7.5.1 Novartis AG Company Summary
7.5.2 Novartis AG Business Overview
7.5.3 Novartis AG Fibrate Drugs Major Product Offerings
7.5.4 Novartis AG Fibrate Drugs Revenue in Global Market (2018-2023)
7.5.5 Novartis AG Key News & Latest Developments
7.6 GlaxoSmithKline plc
7.6.1 GlaxoSmithKline plc Company Summary
7.6.2 GlaxoSmithKline plc Business Overview
7.6.3 GlaxoSmithKline plc Fibrate Drugs Major Product Offerings
7.6.4 GlaxoSmithKline plc Fibrate Drugs Revenue in Global Market (2018-2023)
7.6.5 GlaxoSmithKline plc Key News & Latest Developments
7.7 Sun Pharmaceutical Industries, Inc.
7.7.1 Sun Pharmaceutical Industries, Inc. Company Summary
7.7.2 Sun Pharmaceutical Industries, Inc. Business Overview
7.7.3 Sun Pharmaceutical Industries, Inc. Fibrate Drugs Major Product Offerings
7.7.4 Sun Pharmaceutical Industries, Inc. Fibrate Drugs Revenue in Global Market (2018-2023)
7.7.5 Sun Pharmaceutical Industries, Inc. Key News & Latest Developments
7.8 Macleods Pharmaceuticals Limited
7.8.1 Macleods Pharmaceuticals Limited Company Summary
7.8.2 Macleods Pharmaceuticals Limited Business Overview
7.8.3 Macleods Pharmaceuticals Limited Fibrate Drugs Major Product Offerings
7.8.4 Macleods Pharmaceuticals Limited Fibrate Drugs Revenue in Global Market (2018-2023)
7.8.5 Macleods Pharmaceuticals Limited Key News & Latest Developments
7.9 Aurobindo Pharma
7.9.1 Aurobindo Pharma Company Summary
7.9.2 Aurobindo Pharma Business Overview
7.9.3 Aurobindo Pharma Fibrate Drugs Major Product Offerings
7.9.4 Aurobindo Pharma Fibrate Drugs Revenue in Global Market (2018-2023)
7.9.5 Aurobindo Pharma Key News & Latest Developments
7.10 Abbott
7.10.1 Abbott Company Summary
7.10.2 Abbott Business Overview
7.10.3 Abbott Fibrate Drugs Major Product Offerings
7.10.4 Abbott Fibrate Drugs Revenue in Global Market (2018-2023)
7.10.5 Abbott Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Fibrate Drugs Market Opportunities & Trends in Global Market
Table 2. Fibrate Drugs Market Drivers in Global Market
Table 3. Fibrate Drugs Market Restraints in Global Market
Table 4. Key Players of Fibrate Drugs in Global Market
Table 5. Top Fibrate Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Fibrate Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Fibrate Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Fibrate Drugs Product Type
Table 9. List of Global Tier 1 Fibrate Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Fibrate Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Fibrate Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Fibrate Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Fibrate Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Fibrate Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Fibrate Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Fibrate Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Fibrate Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Fibrate Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Fibrate Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Fibrate Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Fibrate Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Fibrate Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Fibrate Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Fibrate Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Fibrate Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Fibrate Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Fibrate Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Fibrate Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Fibrate Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Teva Pharmaceutical Industries Company Summary
Table 31. Teva Pharmaceutical Industries Fibrate Drugs Product Offerings
Table 32. Teva Pharmaceutical Industries Fibrate Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Teva Pharmaceutical Industries Key News & Latest Developments
Table 34. Pfizer, Inc. Company Summary
Table 35. Pfizer, Inc. Fibrate Drugs Product Offerings
Table 36. Pfizer, Inc. Fibrate Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer, Inc. Key News & Latest Developments
Table 38. Mylan N.V. Company Summary
Table 39. Mylan N.V. Fibrate Drugs Product Offerings
Table 40. Mylan N.V. Fibrate Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Mylan N.V. Key News & Latest Developments
Table 42. Sanofi SA Company Summary
Table 43. Sanofi SA Fibrate Drugs Product Offerings
Table 44. Sanofi SA Fibrate Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Sanofi SA Key News & Latest Developments
Table 46. Novartis AG Company Summary
Table 47. Novartis AG Fibrate Drugs Product Offerings
Table 48. Novartis AG Fibrate Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Novartis AG Key News & Latest Developments
Table 50. GlaxoSmithKline plc Company Summary
Table 51. GlaxoSmithKline plc Fibrate Drugs Product Offerings
Table 52. GlaxoSmithKline plc Fibrate Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. GlaxoSmithKline plc Key News & Latest Developments
Table 54. Sun Pharmaceutical Industries, Inc. Company Summary
Table 55. Sun Pharmaceutical Industries, Inc. Fibrate Drugs Product Offerings
Table 56. Sun Pharmaceutical Industries, Inc. Fibrate Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Sun Pharmaceutical Industries, Inc. Key News & Latest Developments
Table 58. Macleods Pharmaceuticals Limited Company Summary
Table 59. Macleods Pharmaceuticals Limited Fibrate Drugs Product Offerings
Table 60. Macleods Pharmaceuticals Limited Fibrate Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Macleods Pharmaceuticals Limited Key News & Latest Developments
Table 62. Aurobindo Pharma Company Summary
Table 63. Aurobindo Pharma Fibrate Drugs Product Offerings
Table 64. Aurobindo Pharma Fibrate Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Aurobindo Pharma Key News & Latest Developments
Table 66. Abbott Company Summary
Table 67. Abbott Fibrate Drugs Product Offerings
Table 68. Abbott Fibrate Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Abbott Key News & Latest Developments
List of Figures
Figure 1. Fibrate Drugs Segment by Type in 2022
Figure 2. Fibrate Drugs Segment by Application in 2022
Figure 3. Global Fibrate Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Fibrate Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Fibrate Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Fibrate Drugs Revenue in 2022
Figure 8. By Type - Global Fibrate Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Fibrate Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Fibrate Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Fibrate Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Fibrate Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Fibrate Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Fibrate Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Fibrate Drugs Revenue Market Share, 2018-2029
Figure 16. US Fibrate Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Fibrate Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Fibrate Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Fibrate Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Fibrate Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Fibrate Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Fibrate Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Fibrate Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Fibrate Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Fibrate Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Fibrate Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Fibrate Drugs Revenue Market Share, 2018-2029
Figure 28. China Fibrate Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Fibrate Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Fibrate Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Fibrate Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Fibrate Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Fibrate Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Fibrate Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Fibrate Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Fibrate Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Fibrate Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Fibrate Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Fibrate Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Fibrate Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Teva Pharmaceutical Industries Fibrate Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer, Inc. Fibrate Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Mylan N.V. Fibrate Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Sanofi SA Fibrate Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Novartis AG Fibrate Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. GlaxoSmithKline plc Fibrate Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Sun Pharmaceutical Industries, Inc. Fibrate Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Macleods Pharmaceuticals Limited Fibrate Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Aurobindo Pharma Fibrate Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Abbott Fibrate Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
